Form 4 holding
10%+ Owner
Aerovate Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,758,686
- Estimated value
- $73,294,377
- Report date
- 02 Jul 2021
- Price
- $19.50
- Ownership
- Direct
Sofinnova Venture Partners X, L.P. - 10%+ Owner at Jade Biosciences, Inc.
Issuer-level insider activity
- Role
- 10%+ Owner
- Issuer ticker
- JBIO on Nasdaq
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Sofinnova Venture Partners X, L.P. since 12 Aug 2025
Reported holdings for Sofinnova Venture Partners X, L.P. in Jade Biosciences, Inc.
Form 4 holding
10%+ Owner
Aerovate Therapeutics, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 02 Jul 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Sofinnova Venture Partners X, L.P. in Jade Biosciences, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.